Study Evaluating Bifeprunox in Bipolar Depression

Completed · Phase 3

Conditions studied: Depression Bipolar

In brief

The purpose of the study is to investigate whether eight weeks of treatment with flexible doses of Bifeprunox is superior to treatment with placebo in depressed patients with bipolar disorder.

Key facts

Study ID

NCT00245973

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

380

Starts

2005-06-01

Expected to finish

2007-10-01

Last updated by the study team

2007-12-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women 18 to 65 years of age, inclusive.
• Diagnosis of Bipolar Disorder and must be experiencing a depressive episode.

You may not qualify if…

• This is a follow on study to protocol 3168A2-304. Only subjects who have participated in the previous study are eligible.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Beverly Hills, California, United States
• Study site — National City, California, United States
• Study site — Stanford, California, United States
• Study site — Farmington Hills, Connecticut, United States
• Study site — Bradenton, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Smyrna, Georgia, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Terre Haute, Indiana, United States
• Study site — Florence, Kentucky, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Rockville, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Farmington Hills, Michigan, United States
• Study site — Saint Charles, Missouri, United States
• Study site — Clementon, New Jersey, United States
• Study site — Moorestown, New Jersey, United States
• Study site — Lawrence, New York, United States
• Study site — New York, New York, United States
• Study site — New York, New York, United States
• Study site — Staten Island, New York, United States
• Study site — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.